Double stem cell transplant could be Game-Changer for rare blood disorder

NCT ID NCT07499284

Recruiting now Disease control Sponsor: The First Affiliated Hospital of Soochow University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding umbilical cord blood to a half-matched stem cell transplant can help people with aplastic anemia, a serious condition where the bone marrow stops making enough blood cells. About 224 participants aged 14 and older will receive either the combined transplant or standard care. The goal is to see if this approach improves survival, reduces complications like graft-versus-host disease, and helps the new stem cells take hold more successfully.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APLASTIC ANAEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aplastic anemia idiopathic aplastic anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APLASTIC ANAEMIA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hematology Department, The First Affiliated Hospital of Soochow University
RECRUITING

Suzhou, Jiangsu, China 215006, China
Suzhou Hongci Hematology Hospital
RECRUITING

Suzhou, Jiangsu, China 215006, China
The Affiliated Hospital of Xuzhou Medical University
RECRUITING

Xuzhou, Jiangsu, China 221006, China
The First Affiliated Hospital of Zhejiang Chinese Medical University
RECRUITING

Hangzhou, Zhejiang, China 310006, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.